January 31, 2013

3D printing makes its way into cancer research lab

Organovo.png Bioprinting company Organovo today announced a collaboration with Oregon Health & Science University’s Knight Cancer Institute in which it will create 3D models of breast and pancreatic tumors for researchers to use in drug discovery and development. MedCity News reports via @Info3Dprinter.

quotemarksright.jpg... Today, researchers use animal models and cell lines to identify and test potential new drugs. Having more robust, 3D disease models for what Carroll called “preclinical-plus” testing could give researchers better insight into how tumors behave and how they respond to drugs.quotesmarksleft.jpg

Read full article. Organovo press release.